Page last updated: 2024-11-05
resorcinol monobenzoate
Description
Resorcinol monobenzoate is a chemical compound that is used as a sunscreen agent. It is a derivative of resorcinol, a phenolic compound that is found naturally in plants. Resorcinol monobenzoate is synthesized by reacting resorcinol with benzoyl chloride. It is a white solid that is soluble in organic solvents. Resorcinol monobenzoate is an effective sunscreen agent because it absorbs ultraviolet (UV) radiation, preventing it from reaching the skin. It is commonly used in sunscreen products that protect against both UVA and UVB radiation. Resorcinol monobenzoate is studied extensively due to its effectiveness as a sunscreen agent and its potential applications in other areas, such as skin care and cosmetics.'
resorcinol monobenzoate: a colorless UV light absorber that is added to plastic to prevent deterioration by sunlight [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
resorcinol monobenzoate : A benzoate ester resulting from the formal condensation of benzoic acid with resorcinol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 8690 |
| CHEMBL ID | 2260450 |
| CHEBI ID | 156556 |
| SCHEMBL ID | 78117 |
| MeSH ID | M0233016 |
Synonyms (43)
| Synonym |
|---|
| BIDD:ER0042 |
| nsc 4807 |
| einecs 205-241-7 |
| brn 1873897 |
| benzoic acid (3-hydroxyphenyl) ester |
| AKOS015839082 |
| 3-hydroxyphenyl benzoate |
| eastman inhibitor rmb |
| resorcinol monobenzoate |
| wln: qr covr |
| benzoic acid, m-hydroxyphenyl ester |
| nsc-4807 |
| resorcinol, monobenzoate |
| nsc4807 |
| 136-36-7 |
| 1,3-benzenediol, monobenzoate |
| inchi=1/c13h10o3/c14-11-7-4-8-12(9-11)16-13(15)10-5-2-1-3-6-10/h1-9,14 |
| resorcinol monobenzoate, 97% |
| benzoic acid 3-hydroxyphenyl ester |
| B0077 |
| m-hydroxyphenyl benzoate |
| 3-benzoyloxyphenol |
| CHEBI:156556 |
| (3-hydroxyphenyl) benzoate |
| unii-942e82kuwd |
| 942e82kuwd , |
| 1,3-benzenediol, 1-benzoate |
| 1,3-benzenediol,1-benzoate |
| SCHEMBL78117 |
| CHEMBL2260450 |
| resorcinol, benzoate |
| 1,3-benzenediol benzoate |
| H1560 |
| resorcinol benzoate |
| benzoic acid resorcinol ester |
| DTXSID1038878 |
| mfcd00020118 |
| J-006838 |
| EN300-107171 |
| Q27271634 |
| D88598 |
| resorcinolmonobenzoate |
| CS-0308088 |
Research Excerpts
Overview
Resorcinol monobenzoate is an ultraviolet light absorber used in cellulose plastics. It is known to cause allergic contact dermatitis reactions.
Roles (1)
| Role | Description |
|---|
| allergen | A chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (1)
| Class | Description |
|---|
| benzoate ester | Esters of benzoic acid or substituted benzoic acids. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.23
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 22.23 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.29 (4.65) | | Search Engine Demand Index | 19.78 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 4 (66.67%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 2 (33.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |